Masahiro Iizuka - Publications

Efficacy of Biologics in Patients with Ulcerative Colitis Exhibiting Non-Response or Insufficient Response to Cytapheresis.

Journal: Journal of clinical medicine

Published: July 13, 2025

Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy.

Journal: World journal of gastroenterology

Published: May 30, 2022

A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.

Journal: Journal of gastroenterology

Published: July 08, 2021

Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis.

Journal: World journal of gastroenterology

Published: November 04, 2020

Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: July 18, 2020

Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis.

Journal: Internal medicine (Tokyo, Japan)

Published: September 20, 2017

One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics.

Journal: Internal medicine (Tokyo, Japan)

Published: November 18, 2014

Ulcerative colitis accompanied by idiopathic thrombocytopenic purpura and Helicobacter pylori infection.

Journal: Internal medicine (Tokyo, Japan)

Published: March 02, 2013

Molecular cloning reveals nearly half of patients with Crohn's disease have an antibody to peroxiredoxin 6-like protein.

Journal: Journal of gastroenterology and hepatology

Published: April 14, 2012